Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kadin, M. E.
Right arrow Articles by Lange, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kadin, M. E.
Right arrow Articles by Lange, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy

ME Kadin, D Sako, N Berliner, W Franklin, B Woda, M Borowitz, K Ireland, A Schweid, P Herzog and B Lange

We describe a large-cell lymphoma of activated lymphoid cells in six children and adolescents. The presenting clinical features of regressing skin lesions and peripheral lymphadenopathy, sinus infiltration of lymph nodes, and infrequent tumor cell erythrophagocytosis resulted in initial diagnoses of malignant or regressing atypical histiocytosis in five cases. Binucleate and multinucleate tumor cells, sometimes with prominent eosinophilic nucleoli, resembled Reed-Sternberg (RS) cells and occasionally were found in a cytoarchitectural milieu that was consistent with a diagnosis of Hodgkin's disease (HD). The tumor cells did in fact express the HD-associated antigen Ki-1, but unlike most types of HD, the RS-like cells expressed common leukocyte antigen and were negative for Leu-M1. A T cell origin for the malignant cells was demonstrated with monoclonal antibodies in two cases, by focal staining for nonspecific esterase in one case, and by rearrangement of the beta- chain genes for the T cell receptor in a fourth case. These studies provide further evidence that some cases previously interpreted as malignant or regressing atypical histiocytosis and some types of HD are actually T cell disorders.

Volume 68, Issue 5, pp. 1042-1049, 11/01/1986
Copyright © 1986 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
H. M. Amin and R. Lai
Pathobiology of ALK+ anaplastic large-cell lymphoma
Blood, October 1, 2007; 110(7): 2259 - 2267.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
J. P. Greer, M. C. Kinney, and T. P. Loughran Jr.
T Cell and NK Cell Lymphoproliferative Disorders
Hematology, January 1, 2001; 2001(1): 259 - 281.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Stein, H.-D. Foss, H. Durkop, T. Marafioti, G. Delsol, K. Pulford, S. Pileri, and B. Falini
CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
Blood, December 1, 2000; 96(12): 3681 - 3695.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
M. E. Kadin
Cutaneous {gamma}{delta} T-Cell Lymphomas--How and Why Should They Be Recognized?
Arch Dermatol, August 1, 2000; 136(8): 1052 - 1054.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Pfeifer, E. Levi, T. Petrogiannis-Haliotis, L. Lehmann, Z. Wang, and M. E. Kadin
A Murine Xenograft Model for Human CD30+ Anaplastic Large Cell Lymphoma : Successful Growth Inhibition with an Anti-CD30 Antibody (HeFi-1)
Am. J. Pathol., October 1, 1999; 155(4): 1353 - 1359.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Falini, S. Pileri, P. L. Zinzani, A. Carbone, V. Zagonel, C. Wolf-Peeters, G. Verhoef, F. Menestrina, G. Todeschini, M. Paulli, et al.
ALK+ Lymphoma: Clinico-Pathological Findings and Outcome
Blood, April 15, 1999; 93(8): 2697 - 2706.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
F. Millot, A. Robert, Y. Bertrand, F. Mechinaud, G. Laureys, A. Ferster, P. Brock, P. Rohrlich, F. Mazingue, D. Plantaz, et al.
Cutaneous Involvement in Children With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Pediatrics, July 1, 1997; 100(1): 60 - 64.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Pulford, L. Lamant, S. W. Morris, L. H. Butler, K. M. Wood, D. Stroud, G. Delsol, and D. Y. Mason
Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells With the Monoclonal Antibody ALK1
Blood, February 15, 1997; 89(4): 1394 - 1404.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
N. M. Smith, R. W. Byard, M. Vasiliou, D. F. Callen, A. J. Bourne, and A. S.-Y. Leong
Pediatric Anaplastic Large Cell (CD30+) Lymphomas Associated With the t(2;5) (p23;q35) Chromosomal Abnormality
International Journal of Surgical Pathology, July 1, 1993; 1(1): 43 - 49.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1986 by American Society of Hematology         Online ISSN: 1528-0020